Search
for
Sort by
Research 421–450 of 1000+
- Caffeine and Its Role in Regulation the Androgenetic Alopecia.
- Targeted therapy in melanoma
- Prostanoids and Hair Follicles: Implications for Therapy of Hair Disorders
- An industry update: what’s new in the field of therapeutic delivery this month?
- The role of androgens in hormone replacement therapy
- Alopecia Areata
- Answer of Regenerative Therapy Not Hair Treatment Patients with Androgenetic Alopecia Approved for Hairmetrix® Technology - Case Report
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- Development of validated methods for the simultaneous quantification of Finasteride and Tadalafil in newly launched FDA-approved therapeutic combination: greenness assessment using AGP, analytical eco-scale, and GAPI tools
- US clinics marketing unproven and unlicensed adipose-derived autologous stem cell interventions
- Follicular Unit Transplantation for Male and Female Pattern Hair Loss and Restoring Eyebrows
- Surgical hair restoration
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- Hair Care Cosmetics Regulation in Different Countries – A Comparative Study
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Novel agents for the treatment of alopecia
- Androgen treatment of postmenopausal women
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges
- Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database